Development of new abortion medications by using existing medications in new ways
Gynuity United States
Mifepristone and misoprostol are gold standard abortifacients, but access to mifepristone is limited. This project team aims to establish proof-of-concept for further clinical development of one or more existing medications as a safe and effective abortifacient in order to address the unmet need for safe abortion and expand client choice. During this grant period, the team will conduct a comprehensive literature review to assess available data on several drugs and will evaluate the potential effectiveness of each, assess possible barriers to development and assess the likelihood of each to fill market gaps. In consultation with an Advisory Group, the team will then conduct a preliminary dosing and safety study with the most promising candidate.